The Veteran's claims for a 40 percent rating for prostate cancer, an earlier effective date for TDIU, and eligibility for DEA were granted, with the effective date set to September 4, 2020.
The deciding factor: The evidence supports that the Veteran's symptoms of urinary frequency began at least as early as September 4, 2020, which is when he filed his claim for an increased rating. The Board resolved all reasonable doubt in favor of the Veteran and granted the claims effective from this date.
- Claimed conditions
- Prostate cancer
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 40%
- Decision date
- November 7, 2024
- Citation
- A24072748
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board restored the Veteran's 100 percent disability rating for his service-connected prostate cancer, effective September 1, 2024.
- Partly granted
The Board denied a higher disability rating for PTSD and granted service connection for lumbosacral strain, while denying service connection for prostate cancer, erectile dysfunction, hypertension, and nuclear sclerosis and dry eye syndrome.
- Dismissed
The appeals for service connection and higher initial rating were dismissed due to concurrent election of review options.
- Granted
The Veteran was granted an earlier effective date of August 10, 2022, for the grant of a total disability rating due to individual unemployability (TDIU).
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.